Liraglutide 3.0 mg in the treatment of adults with obesity and prediabetes using real-world UK data: A clinical evaluation of a multi-ethnic population.

UK guidelines recommend liraglutide 3.0 mg in adults treated within specialist weight management services with BMI ≥35 kg/m, prediabetes and high cardiovascular disease risk. We aimed to clinically evaluate liraglutide 3.

A Tale of Two Waves: Changes in the Use of Noninvasive Ventilation and Prone Positioning in Critical Care Management of Coronavirus Disease 2019.

Unlabelled: New treatments and increased experience are changing the management of hospitalized coronavirus disease 2019 patients but the impact on ICU management is unclear.

Objectives: To examine characteristics, ventilatory management, and outcomes of critically ill patients in two distinct waves of the pandemic.

Design Setting And Participants: Observational cohort study in an ICU in a single-center university-affiliated U.

Diet quality, food insecurity and risk of cardiovascular diseases among adults living with HIV/AIDS: a scoping review protocol.

Introduction: Cardiovascular diseases (CVDs) are the single greatest contributor to global mortality. The successful introduction and scale-up of antiretroviral therapy (ART) delivered a reduction in HIV mortality. Consequently, an association was found between the scale-up of ART and an increased prevalence of comorbidities among people living with HIV (PLWH) such as hypertension and dyslipidaemia.

Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study.

Background: Type 2 diabetes (T2D) has a reported greater prevalence and poorer treatment outcomes in people living with HIV (PLWH) than comparable HIV-uninfected cohorts. We conducted a cross-sectional study to delineate the factors driving T2D in PLWH in an ethnically diverse cohort, and additionally observed how these have changed over time.

Setting: We studied a diverse HIV cohort in London to determine the prevalence and risk factors for T2D, and compared them to a cohort studied 10 years previously.

A cross-sectional randomised study of fracture risk in people with HIV infection in the probono 1 study.

Objective: To determine comparative fracture risk in HIV patients compared with uninfected controls.

Design: A randomised cross-sectional study assessing bone mineral density (BMD), fracture history and risk factors in the 2 groups.

Setting: Hospital Outpatients.

The assessment of metabolic syndrome in UK patients with HIV using two different definitions: CREATE 2 study.

Objective: To determine the prevalence and clinical associations of the metabolic syndrome (M-IRS) in an HIV cohort.

Methods And Design: Data was collected prospectively on demographics, anthropometry, HIV disease, drug regimens and cardiometabolic risk factors using a two-centre cross-sectional cohort study design. M-IRS was diagnosed by National Cholesterol Education Program (NCEP) and International Diabetes Federation (IDF) criteria.